Enclomiphene is a selective estrogen receptor modulator (SERM) and the trans isomer of clomiphene citrate, originally developed for the treatment of ovarian dysfunction in women. Researchers primarily study enclomiphene for its potential role in addressing male hypogonadism, particularly in preserving fertility while increasing testosterone levels. Key findings from recent studies indicate that enclomiphene significantly elevates serum testosterone, luteinizing hormone (LH), and follicle-stimulating hormone (FSH) levels without adversely affecting semen parameters. Current research continues to explore enclomiphene's efficacy and safety in various male populations, suggesting it may serve as a viable alternative to traditional testosterone replacement therapies.